ART-2713
N/A
Report date: 2026/03/27 20:01:50
NME
Base Information
Drug NameART-2713
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca PlcNeomed IncPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesArtelo Biosciences Inc
Inactive CompaniesAstrazeneca Plc
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A